Postprandial active GIPbioassay and active GIPELISA levels in T2DM subjects with DPP-4 inhibitor were significantly higher than those in T2DM without DPP-4 inhibitor (Figures 2B,C). This evidence concerns the gene DPP4 and type 2 diabetes mellitus.